Advanced Biomed Inc. (ADVB): Total Liabilities
$3.03M
As of 2025-06-30
$1.44M
As of 2026-03-31
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $3.03M | +8.5% | 2025-10-08, Balance as of period end |
| 2024-06-30 | $2.80M | n/a | 2025-10-08, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | 2025-06-30 | $3.03M | +8.5% |
| Renalytix plc (RNLXY) | 2024-06-30 | $15.83M | -33.1% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | $43.58M | +17.8% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $837.3K | -27.4% |
| YD Bio Ltd (YDES) | 2025-12-31 | $16.64M | n/m |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
Compare ADVB, RNLXY, BGLC, FCHS side by side · Screen every company in Services-Medical Laboratories ↗